Dupilumab Reduces Exacerbations And Improves Lung Function Regardless Of Prior Asthma Exacerbation Status: LIBERTY ASTHMA TRAVERSE Open-Label Extension Study

被引：0

作者：

Papi, Alberto ^{[1
]}

Castro, Mario ^{[2
]}

Busse, William ^{[3
]}

Korn, Stephanie ^{[4
,5
]}

Xia, Changming ^{[6
]}

Soler, Xavier ^{[6
]}

Pandit-Abid, Nami ^{[7
]}

Radwan, Amr ^{[6
]}

Jacob-Nara, Juby ^{[7
]}

Rowe, Paul ^{[7
]}

Deniz, Yamo ^{[6
]}

机构：

[1] Univ Ferrara, S Anna Univ Hosp, Resp Med Unit, Ferrara, Italy

[2] Univ Kansas, Sch Med, Kansas City, KS USA

[3] Univ Wisconsin, UW Allergy Pulm & Crit Care Med, Sch Med & Publ Hlth, Madison, WI USA

[4] IKF Pneumol Mainz, Mainz, Germany

[5] Thoraxklin Heidelberg, Mainz, Germany

[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[7] Sanofi, Bridgewater, NJ USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2023年 / 151卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

597

引用

页码：AB193 / AB193

页数：1

共 50 条

[21] Dupilumab Reduced Severe Exacerbation Rates and Improved Pre-bronchodilator Fev1 in Patients With Moderate-to-Severe Asthma Regardless of Exacerbation History of ≥1, ≥2, or ≥3 Prior Exacerbations: Liberty Asthma Traverse [J].

Maspero, J. F. ;

Corren, J. ;

Katelaris, C. ;

Castro, M. ;

Humbert, M. J. ;

Halpin, D. M. ;

Altincatal, A. ;

Pandit-Abid, N. ;

Soler, X. ;

Radwan, A. ;

Jacob-Nara, J. A. ;

Deniz, Y. M. ;

Rowe, P. J. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207

[22] Dupilumab reduced rates of severe exacerbations and improved pre-bronchodilator FEV1 in patients with moderate to severe asthma regardless of exacerbation history: LIBERTY ASTHMA TRAVERSE [J].

Corren, J. ;

Katelaris, C. H. ;

Castro, M. ;

Maspero, J. F. ;

Humbert, M. ;

Halpin, D. M. ;

Altincatal, A. ;

Pandit-Abid, N. ;

Soler, X. ;

Radwan, A. ;

Jacob-Nara, J. A. ;

Deniz, Y. ;

Rowe, P. J. .

ALLERGOLOGIE, 2023, 46 (08) :544-545

[23] Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study [J].

Hanania, N. A. ;

Bateman, E. D. ;

Castro, M. ;

Pavord, I. D. ;

Papi, A. ;

FitzGerald, J. M. ;

Maspero, J. F. ;

Katelaris, C. ;

Singh, D. ;

Rice, M. S. ;

Rowe, P. ;

Lu, Y. ;

Amin, N. ;

Staudinger, H. W. ;

Graham, N. M. H. ;

Teper, A. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199

[24] DUPILUMAB IMPROVES LUNG FUNCTION IN PATIENTS IRRESPECTIVE OF ON-STUDY ASTHMA EXACERBATIONS [J].

Castro, Mario ;

Rabe, Klaus ;

Corren, Jonathan ;

Jackson, Daniel ;

Rogers, Linda ;

Pavord, Ian ;

Papi, Alberto ;

Daizadeh, Nadia ;

Ortiz, Benjamin ;

Deniz, Yamo ;

Pandit-Abid, Nami ;

Rowe, Paul .

CHEST, 2020, 158 (04) :1729A-1733A

[25] LONG-TERM EFFECT OF DUPILUMAB ON LUNG FUNCTION IN PATIENTS WITH TYPE 2 ASTHMA: LIBERTY ASTHMA TRAVERSE STUDY [J].

Papi, Alberto ;

Castro, Mario ;

Corren, Jonathan ;

Pavord, Ian ;

Tohda, Yuji ;

Daizadeh, Nadia ;

Ortiz, Benjamin ;

Djandji, Michel ;

Ruddy, Marcella ;

Laws, Elizabeth ;

Mannent, Leda ;

Amin, Nikhil ;

Gall, Rebecca ;

Jacob-Nara, Juby ;

Deniz, Yamo ;

Rowe, Paul ;

Lederer, David ;

Hardin, Megan .

CHEST, 2021, 160 (04) :1854A-1858A

[26] Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study [J].

Wechsler, Michael E. ;

Ford, Linda B. ;

Maspero, Jorge F. ;

Pavord, Ian D. ;

Papi, Alberto ;

Bourdin, Arnaud ;

Watz, Henrik ;

Castro, Mario ;

Nenasheva, Natalia M. ;

Tohda, Yuji ;

Langton, David ;

Cardona, Guido ;

Domingo, Christian ;

Park, Hae Sim ;

Chapman, Kenneth R. ;

Mao, Xuezhou ;

Zhang, Yi ;

Khan, Asif H. ;

Deniz, Yamo ;

Rowe, Paul J. ;

Kapoor, Upender ;

Khokhar, Faisal A. ;

Mannent, Leda P. ;

Ruddy, Marcella ;

Laws, Elizabeth ;

Amin, Nikhil ;

Hardin, Megan .

LANCET RESPIRATORY MEDICINE, 2022, 10 (01) :11-25

[27] Once-daily tiotropium improves lung function and reduces risk of asthma exacerbation/worsening in patients with symptomatic asthma, regardless of allergic status [J].

Dahl, R. ;

Paggiaro, P. ;

Engel, M. ;

Sigmund, R. ;

Moroni-Zentgraf, P. ;

Bateman, E. ;

Kerstjens, H. A. M. .

ALLERGY, 2013, 68 :40-41

[28] Dupilumab improved lung function and reduces exacerbations in patients with 1, 2, or 3 prior exacerbations: TRAVERSE [J].

Corren, J. ;

Castro, M. ;

Maspero, J. F. ;

Humbert, M. ;

Halpin, D. M. G. ;

Altincatal, A. ;

Pandit-Abid, N. ;

Soler, X. ;

Siddiqui, S. ;

Jacob-Nara, J. A. ;

Deniz, Y. ;

Rowe, P. J. ;

Maspero, J. F. .

EUROPEAN RESPIRATORY JOURNAL, 2022, 60

[29] Long-Term Dupilumab Treatment in Moderate-to-Severe Asthma with Type 2 Inflammation: Open Label LIBERTY ASTHMA TRAVERSE Study [J].

Wechsler, M. ;

Pavord, I. D. ;

Papi, A. ;

Chapman, K. R. ;

Mao, X. ;

Ortiz, B. ;

Djandji, M. ;

Ruddy, M. K. ;

Laws, E. ;

Amin, N. ;

Lederer, D. J. ;

Hardin, M. E. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)

[30] Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial [J].

Sher, Lawrence D. ;

Wechsler, Michael E. ;

Rabe, Klaus F. ;

Maspero, Jorge F. ;

Daizadeh, Nadia ;

Mao, Xuezhou ;

Ortiz, Benjamin ;

Mannent, Leda P. ;

Laws, Elizabeth ;

Ruddy, Marcella ;

Pandit-Abid, Nami ;

Jacob-Nara, Juby A. ;

Gall, Rebecca ;

Rowe, Paul J. ;

Deniz, Yamo ;

Lederer, David J. ;

Hardin, Megan .

CHEST, 2022, 162 (01) :46-55

← 1 2 3 4 5 →